Structure

Physi-Chem Properties

Molecular Weight:  410.32
Volume:  465.653
LogP:  6.049
LogD:  5.407
LogS:  -5.827
# Rotatable Bonds:  4
TPSA:  37.3
# H-Bond Aceptor:  2
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.527
Synthetic Accessibility Score:  4.889
Fsp3:  0.75
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.733
MDCK Permeability:  3.1983341614250094e-05
Pgp-inhibitor:  0.94
Pgp-substrate:  0.083
Human Intestinal Absorption (HIA):  0.046
20% Bioavailability (F20%):  0.861
30% Bioavailability (F30%):  0.782

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.015
Plasma Protein Binding (PPB):  91.499755859375%
Volume Distribution (VD):  1.027
Pgp-substrate:  1.8881148099899292%

ADMET: Metabolism

CYP1A2-inhibitor:  0.068
CYP1A2-substrate:  0.704
CYP2C19-inhibitor:  0.374
CYP2C19-substrate:  0.888
CYP2C9-inhibitor:  0.736
CYP2C9-substrate:  0.1
CYP2D6-inhibitor:  0.05
CYP2D6-substrate:  0.035
CYP3A4-inhibitor:  0.937
CYP3A4-substrate:  0.918

ADMET: Excretion

Clearance (CL):  3.382
Half-life (T1/2):  0.047

ADMET: Toxicity

hERG Blockers:  0.002
Human Hepatotoxicity (H-HT):  0.136
Drug-inuced Liver Injury (DILI):  0.078
AMES Toxicity:  0.007
Rat Oral Acute Toxicity:  0.9
Maximum Recommended Daily Dose:  0.962
Skin Sensitization:  0.138
Carcinogencity:  0.027
Eye Corrosion:  0.004
Eye Irritation:  0.021
Respiratory Toxicity:  0.983

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475022

Natural Product ID:  NPC475022
Common Name*:   Topsentisterol D2
IUPAC Name:   (3S,10S,13R,14R,17R)-17-[(E,2R)-5,6-dimethylhept-3-en-2-yl]-3-hydroxy-10,13-dimethyl-1,2,3,4,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-7-one
Synonyms:   Topsentisterol D2
Standard InCHIKey:  UOHNARRKDSHFLD-FIRTXFBRSA-N
Standard InCHI:  InChI=1S/C28H42O2/c1-17(2)18(3)7-8-19(4)22-9-10-23-26-24(12-14-28(22,23)6)27(5)13-11-21(29)15-20(27)16-25(26)30/h7-8,16-19,21-23,29H,9-15H2,1-6H3/b8-7+/t18?,19-,21+,22-,23+,27+,28-/m1/s1
SMILES:  CC(C)C(C)C=CC(C)C1CCC2C1(CCC3=C2C(=O)C=C4C3(CCC(C4)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL492164
PubChem CID:   20839237
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0003567] Ergostane steroids
          • [CHEMONTID:0001403] Ergosterols and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32840 topsentia sp. Species n.a. Eukaryota n.a. At the 20 m depth, the coast of Jeju Island, Korea 2002-OCT PMID[16643027]
NPO32840 topsentia sp. Species n.a. Eukaryota n.a. the coast of Jeju Island, Korea 2002-OCT PMID[16643027]
NPO32840 topsentia sp. Species n.a. Eukaryota n.a. n.a. n.a. PMID[17190456]
NPO32840 topsentia sp. Species n.a. Eukaryota n.a. n.a. n.a. PMID[19653640]
NPO32840 topsentia sp. Species n.a. Eukaryota n.a. n.a. n.a. PMID[2045823]
NPO32840 topsentia sp. Species n.a. Eukaryota n.a. n.a. n.a. PMID[20806907]
NPO32840 topsentia sp. Species n.a. Eukaryota n.a. n.a. n.a. PMID[8145229]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 = 8.5 ug ml-1 PMID[480907]
NPT146 Cell Line SK-OV-3 Homo sapiens ED50 = 13.5 ug ml-1 PMID[480907]
NPT147 Cell Line SK-MEL-2 Homo sapiens ED50 = 6.3 ug ml-1 PMID[480907]
NPT574 Cell Line XF498 Homo sapiens ED50 = 4.6 ug ml-1 PMID[480907]
NPT148 Cell Line HCT-15 Homo sapiens ED50 = 8.4 ug ml-1 PMID[480907]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475022 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC118648
1.0 High Similarity NPC222613
0.9634 High Similarity NPC58063
0.9518 High Similarity NPC471722
0.9512 High Similarity NPC474733
0.9512 High Similarity NPC31564
0.9512 High Similarity NPC474778
0.9512 High Similarity NPC474732
0.9512 High Similarity NPC145879
0.9506 High Similarity NPC473246
0.9398 High Similarity NPC475740
0.9277 High Similarity NPC72133
0.9268 High Similarity NPC214043
0.9268 High Similarity NPC59453
0.9268 High Similarity NPC221758
0.9268 High Similarity NPC85774
0.9176 High Similarity NPC31985
0.9176 High Similarity NPC1015
0.9176 High Similarity NPC86319
0.9176 High Similarity NPC268406
0.9176 High Similarity NPC186688
0.9176 High Similarity NPC26959
0.9176 High Similarity NPC275740
0.9167 High Similarity NPC136548
0.9157 High Similarity NPC469948
0.907 High Similarity NPC48010
0.907 High Similarity NPC191684
0.9059 High Similarity NPC143767
0.9059 High Similarity NPC131470
0.9048 High Similarity NPC51014
0.9036 High Similarity NPC472265
0.9036 High Similarity NPC33913
0.9024 High Similarity NPC151519
0.8966 High Similarity NPC272746
0.8966 High Similarity NPC475806
0.8953 High Similarity NPC473999
0.8953 High Similarity NPC309603
0.8941 High Similarity NPC93778
0.8929 High Similarity NPC474083
0.8929 High Similarity NPC470574
0.8916 High Similarity NPC476082
0.8916 High Similarity NPC278648
0.8889 High Similarity NPC472490
0.8876 High Similarity NPC259286
0.8864 High Similarity NPC474736
0.8864 High Similarity NPC250575
0.8864 High Similarity NPC69454
0.8864 High Similarity NPC134826
0.8851 High Similarity NPC183283
0.8837 High Similarity NPC328313
0.8837 High Similarity NPC471724
0.8837 High Similarity NPC328539
0.8824 High Similarity NPC94755
0.8824 High Similarity NPC155011
0.881 High Similarity NPC321187
0.881 High Similarity NPC82902
0.881 High Similarity NPC161423
0.881 High Similarity NPC329043
0.881 High Similarity NPC58841
0.881 High Similarity NPC227064
0.881 High Similarity NPC237712
0.878 High Similarity NPC472478
0.878 High Similarity NPC2482
0.8778 High Similarity NPC249954
0.8765 High Similarity NPC82635
0.8764 High Similarity NPC166906
0.8764 High Similarity NPC8993
0.8764 High Similarity NPC245972
0.8764 High Similarity NPC196485
0.875 High Similarity NPC63748
0.875 High Similarity NPC473998
0.875 High Similarity NPC233116
0.875 High Similarity NPC19114
0.8736 High Similarity NPC32830
0.8736 High Similarity NPC474245
0.8736 High Similarity NPC76879
0.8736 High Similarity NPC119416
0.8736 High Similarity NPC477943
0.8721 High Similarity NPC159046
0.8721 High Similarity NPC233836
0.8721 High Similarity NPC187376
0.8721 High Similarity NPC141292
0.8706 High Similarity NPC471224
0.8706 High Similarity NPC474218
0.8706 High Similarity NPC202868
0.869 High Similarity NPC470015
0.869 High Similarity NPC168188
0.8681 High Similarity NPC108078
0.8675 High Similarity NPC136150
0.8667 High Similarity NPC470016
0.8667 High Similarity NPC317586
0.8667 High Similarity NPC472932
0.8652 High Similarity NPC475255
0.8652 High Similarity NPC472930
0.8652 High Similarity NPC12722
0.8636 High Similarity NPC69622
0.8636 High Similarity NPC126993
0.8636 High Similarity NPC129913
0.8636 High Similarity NPC85173
0.8621 High Similarity NPC53911
0.8621 High Similarity NPC242864
0.8621 High Similarity NPC292491
0.8621 High Similarity NPC310752
0.8605 High Similarity NPC327115
0.8605 High Similarity NPC469994
0.8605 High Similarity NPC89077
0.8605 High Similarity NPC28252
0.8605 High Similarity NPC20688
0.8605 High Similarity NPC55309
0.8605 High Similarity NPC94666
0.8571 High Similarity NPC96859
0.8571 High Similarity NPC305483
0.8571 High Similarity NPC320514
0.8571 High Similarity NPC260956
0.8571 High Similarity NPC328162
0.8556 High Similarity NPC111015
0.8539 High Similarity NPC131872
0.8539 High Similarity NPC185936
0.8539 High Similarity NPC168027
0.8537 High Similarity NPC469996
0.8523 High Similarity NPC77168
0.8523 High Similarity NPC102414
0.8523 High Similarity NPC2983
0.8523 High Similarity NPC84271
0.8506 High Similarity NPC90652
0.8506 High Similarity NPC317590
0.8506 High Similarity NPC142361
0.8506 High Similarity NPC287079
0.8506 High Similarity NPC474684
0.8506 High Similarity NPC99909
0.8488 Intermediate Similarity NPC29447
0.8488 Intermediate Similarity NPC197823
0.8488 Intermediate Similarity NPC311702
0.8488 Intermediate Similarity NPC94531
0.8488 Intermediate Similarity NPC123319
0.8478 Intermediate Similarity NPC320306
0.8478 Intermediate Similarity NPC43747
0.8471 Intermediate Similarity NPC41539
0.8462 Intermediate Similarity NPC469995
0.8462 Intermediate Similarity NPC174948
0.8462 Intermediate Similarity NPC127063
0.8462 Intermediate Similarity NPC318282
0.8462 Intermediate Similarity NPC271195
0.8462 Intermediate Similarity NPC173875
0.8452 Intermediate Similarity NPC14151
0.8452 Intermediate Similarity NPC38350
0.8452 Intermediate Similarity NPC201912
0.8452 Intermediate Similarity NPC116797
0.8452 Intermediate Similarity NPC121984
0.8452 Intermediate Similarity NPC477372
0.8444 Intermediate Similarity NPC472942
0.8444 Intermediate Similarity NPC109305
0.8444 Intermediate Similarity NPC474807
0.8427 Intermediate Similarity NPC320026
0.8409 Intermediate Similarity NPC193360
0.8409 Intermediate Similarity NPC44181
0.8409 Intermediate Similarity NPC474677
0.8409 Intermediate Similarity NPC470417
0.8391 Intermediate Similarity NPC473168
0.8391 Intermediate Similarity NPC472974
0.8387 Intermediate Similarity NPC114274
0.8387 Intermediate Similarity NPC197386
0.8387 Intermediate Similarity NPC235464
0.8387 Intermediate Similarity NPC166745
0.8387 Intermediate Similarity NPC103051
0.8372 Intermediate Similarity NPC165064
0.8372 Intermediate Similarity NPC180834
0.837 Intermediate Similarity NPC456
0.837 Intermediate Similarity NPC328371
0.837 Intermediate Similarity NPC472941
0.837 Intermediate Similarity NPC117133
0.8353 Intermediate Similarity NPC73882
0.8353 Intermediate Similarity NPC321289
0.8353 Intermediate Similarity NPC327969
0.8353 Intermediate Similarity NPC193347
0.8352 Intermediate Similarity NPC474690
0.8352 Intermediate Similarity NPC473162
0.8352 Intermediate Similarity NPC292793
0.8333 Intermediate Similarity NPC155304
0.8333 Intermediate Similarity NPC297265
0.8333 Intermediate Similarity NPC26888
0.8316 Intermediate Similarity NPC473424
0.8315 Intermediate Similarity NPC54689
0.8315 Intermediate Similarity NPC475921
0.8315 Intermediate Similarity NPC128496
0.8315 Intermediate Similarity NPC310010
0.8315 Intermediate Similarity NPC474704
0.8315 Intermediate Similarity NPC123912
0.8315 Intermediate Similarity NPC326627
0.8315 Intermediate Similarity NPC214387
0.8313 Intermediate Similarity NPC275910
0.8298 Intermediate Similarity NPC327431
0.8298 Intermediate Similarity NPC112167
0.8298 Intermediate Similarity NPC316964
0.8295 Intermediate Similarity NPC472481
0.8295 Intermediate Similarity NPC138756
0.8295 Intermediate Similarity NPC472482
0.8295 Intermediate Similarity NPC96496
0.8295 Intermediate Similarity NPC475772
0.8295 Intermediate Similarity NPC472484

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475022 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9268 High Similarity NPD4786 Approved
0.9024 High Similarity NPD3667 Approved
0.8966 High Similarity NPD6079 Approved
0.8953 High Similarity NPD5328 Approved
0.8824 High Similarity NPD3618 Phase 1
0.8824 High Similarity NPD5279 Phase 3
0.881 High Similarity NPD3666 Approved
0.881 High Similarity NPD3133 Approved
0.881 High Similarity NPD3665 Phase 1
0.8444 Intermediate Similarity NPD4202 Approved
0.8391 Intermediate Similarity NPD5690 Phase 2
0.837 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.837 Intermediate Similarity NPD5222 Approved
0.837 Intermediate Similarity NPD5221 Approved
0.8353 Intermediate Similarity NPD4223 Phase 3
0.8353 Intermediate Similarity NPD4221 Approved
0.8315 Intermediate Similarity NPD4753 Phase 2
0.828 Intermediate Similarity NPD5173 Approved
0.8276 Intermediate Similarity NPD5329 Approved
0.8242 Intermediate Similarity NPD6399 Phase 3
0.8182 Intermediate Similarity NPD5280 Approved
0.8182 Intermediate Similarity NPD4694 Approved
0.8172 Intermediate Similarity NPD4697 Phase 3
0.8171 Intermediate Similarity NPD7339 Approved
0.8171 Intermediate Similarity NPD6942 Approved
0.8161 Intermediate Similarity NPD4197 Approved
0.8161 Intermediate Similarity NPD3668 Phase 3
0.8105 Intermediate Similarity NPD5285 Approved
0.8105 Intermediate Similarity NPD4696 Approved
0.8105 Intermediate Similarity NPD5286 Approved
0.8085 Intermediate Similarity NPD4755 Approved
0.8065 Intermediate Similarity NPD4629 Approved
0.8065 Intermediate Similarity NPD5210 Approved
0.8049 Intermediate Similarity NPD4687 Approved
0.8049 Intermediate Similarity NPD5733 Approved
0.8021 Intermediate Similarity NPD5223 Approved
0.7978 Intermediate Similarity NPD4689 Approved
0.7978 Intermediate Similarity NPD7146 Approved
0.7978 Intermediate Similarity NPD5205 Approved
0.7978 Intermediate Similarity NPD4138 Approved
0.7978 Intermediate Similarity NPD4693 Phase 3
0.7978 Intermediate Similarity NPD7521 Approved
0.7978 Intermediate Similarity NPD7334 Approved
0.7978 Intermediate Similarity NPD4690 Approved
0.7978 Intermediate Similarity NPD4688 Approved
0.7978 Intermediate Similarity NPD6409 Approved
0.7978 Intermediate Similarity NPD6684 Approved
0.7978 Intermediate Similarity NPD5330 Approved
0.7938 Intermediate Similarity NPD5225 Approved
0.7938 Intermediate Similarity NPD4633 Approved
0.7938 Intermediate Similarity NPD5211 Phase 2
0.7938 Intermediate Similarity NPD5224 Approved
0.7938 Intermediate Similarity NPD5226 Approved
0.7935 Intermediate Similarity NPD7515 Phase 2
0.7935 Intermediate Similarity NPD5281 Approved
0.7935 Intermediate Similarity NPD5284 Approved
0.7917 Intermediate Similarity NPD4700 Approved
0.7901 Intermediate Similarity NPD4747 Approved
0.7895 Intermediate Similarity NPD6084 Phase 2
0.7895 Intermediate Similarity NPD6083 Phase 2
0.7882 Intermediate Similarity NPD3617 Approved
0.7872 Intermediate Similarity NPD5695 Phase 3
0.7857 Intermediate Similarity NPD5174 Approved
0.7857 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD5175 Approved
0.7841 Intermediate Similarity NPD4788 Approved
0.7805 Intermediate Similarity NPD5276 Approved
0.7802 Intermediate Similarity NPD4518 Approved
0.7802 Intermediate Similarity NPD5737 Approved
0.7802 Intermediate Similarity NPD6672 Approved
0.7802 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7802 Intermediate Similarity NPD6903 Approved
0.7791 Intermediate Similarity NPD4195 Approved
0.7778 Intermediate Similarity NPD5141 Approved
0.7778 Intermediate Similarity NPD4137 Phase 3
0.7723 Intermediate Similarity NPD6899 Approved
0.7723 Intermediate Similarity NPD6881 Approved
0.7701 Intermediate Similarity NPD4695 Discontinued
0.7701 Intermediate Similarity NPD8259 Clinical (unspecified phase)
0.77 Intermediate Similarity NPD5739 Approved
0.77 Intermediate Similarity NPD7128 Approved
0.77 Intermediate Similarity NPD6675 Approved
0.77 Intermediate Similarity NPD6402 Approved
0.7683 Intermediate Similarity NPD4691 Approved
0.7677 Intermediate Similarity NPD4754 Approved
0.7667 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD4096 Approved
0.7624 Intermediate Similarity NPD5697 Approved
0.7619 Intermediate Similarity NPD4058 Approved
0.7614 Intermediate Similarity NPD4692 Approved
0.7614 Intermediate Similarity NPD4139 Approved
0.759 Intermediate Similarity NPD7152 Approved
0.759 Intermediate Similarity NPD7150 Approved
0.759 Intermediate Similarity NPD7151 Approved
0.7582 Intermediate Similarity NPD4623 Approved
0.7582 Intermediate Similarity NPD4519 Discontinued
0.7582 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7579 Intermediate Similarity NPD7748 Approved
0.7573 Intermediate Similarity NPD6883 Approved
0.7573 Intermediate Similarity NPD7290 Approved
0.7573 Intermediate Similarity NPD7102 Approved
0.7549 Intermediate Similarity NPD4729 Approved
0.7549 Intermediate Similarity NPD7320 Approved
0.7549 Intermediate Similarity NPD6011 Approved
0.7549 Intermediate Similarity NPD5168 Approved
0.7549 Intermediate Similarity NPD4730 Approved
0.7525 Intermediate Similarity NPD4767 Approved
0.7525 Intermediate Similarity NPD4768 Approved
0.75 Intermediate Similarity NPD6649 Approved
0.75 Intermediate Similarity NPD8130 Phase 1
0.75 Intermediate Similarity NPD6847 Approved
0.75 Intermediate Similarity NPD6869 Approved
0.75 Intermediate Similarity NPD6650 Approved
0.75 Intermediate Similarity NPD7525 Registered
0.75 Intermediate Similarity NPD6617 Approved
0.7476 Intermediate Similarity NPD6012 Approved
0.7476 Intermediate Similarity NPD6014 Approved
0.7476 Intermediate Similarity NPD6013 Approved
0.7476 Intermediate Similarity NPD6373 Approved
0.7476 Intermediate Similarity NPD6372 Approved
0.7474 Intermediate Similarity NPD5133 Approved
0.7471 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD7143 Approved
0.747 Intermediate Similarity NPD7144 Approved
0.7451 Intermediate Similarity NPD5701 Approved
0.7449 Intermediate Similarity NPD5696 Approved
0.7447 Intermediate Similarity NPD5207 Approved
0.7429 Intermediate Similarity NPD6882 Approved
0.7429 Intermediate Similarity NPD8297 Approved
0.7412 Intermediate Similarity NPD6926 Approved
0.7412 Intermediate Similarity NPD4785 Approved
0.7412 Intermediate Similarity NPD6924 Approved
0.7412 Intermediate Similarity NPD4784 Approved
0.7404 Intermediate Similarity NPD5249 Phase 3
0.7404 Intermediate Similarity NPD5247 Approved
0.7404 Intermediate Similarity NPD5135 Approved
0.7404 Intermediate Similarity NPD4634 Approved
0.7404 Intermediate Similarity NPD5251 Approved
0.7404 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7404 Intermediate Similarity NPD5250 Approved
0.7404 Intermediate Similarity NPD5169 Approved
0.7404 Intermediate Similarity NPD5248 Approved
0.7381 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7379 Intermediate Similarity NPD5128 Approved
0.7368 Intermediate Similarity NPD5694 Approved
0.7368 Intermediate Similarity NPD6050 Approved
0.7349 Intermediate Similarity NPD6923 Approved
0.7349 Intermediate Similarity NPD6922 Approved
0.7347 Intermediate Similarity NPD7902 Approved
0.734 Intermediate Similarity NPD6080 Approved
0.734 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.734 Intermediate Similarity NPD6904 Approved
0.734 Intermediate Similarity NPD6673 Approved
0.7333 Intermediate Similarity NPD5216 Approved
0.7333 Intermediate Similarity NPD5215 Approved
0.7333 Intermediate Similarity NPD5127 Approved
0.7333 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD5217 Approved
0.7315 Intermediate Similarity NPD7115 Discovery
0.7303 Intermediate Similarity NPD4748 Discontinued
0.7282 Intermediate Similarity NPD6412 Phase 2
0.7273 Intermediate Similarity NPD7638 Approved
0.7263 Intermediate Similarity NPD5692 Phase 3
0.7241 Intermediate Similarity NPD6933 Approved
0.7234 Intermediate Similarity NPD5208 Approved
0.7229 Intermediate Similarity NPD3621 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6868 Approved
0.7204 Intermediate Similarity NPD6098 Approved
0.72 Intermediate Similarity NPD7640 Approved
0.72 Intermediate Similarity NPD7639 Approved
0.7196 Intermediate Similarity NPD4632 Approved
0.7188 Intermediate Similarity NPD6411 Approved
0.7176 Intermediate Similarity NPD4243 Approved
0.7159 Intermediate Similarity NPD6932 Approved
0.7143 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.713 Intermediate Similarity NPD5167 Approved
0.7128 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD8264 Approved
0.71 Intermediate Similarity NPD5290 Discontinued
0.7097 Intermediate Similarity NPD5363 Approved
0.7091 Intermediate Similarity NPD6335 Approved
0.7083 Intermediate Similarity NPD5785 Approved
0.7079 Intermediate Similarity NPD7145 Approved
0.7073 Intermediate Similarity NPD3171 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD3527 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD5362 Discontinued
0.7059 Intermediate Similarity NPD5091 Approved
0.7059 Intermediate Similarity NPD4244 Approved
0.7059 Intermediate Similarity NPD4789 Approved
0.7059 Intermediate Similarity NPD4245 Approved
0.7041 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD7900 Approved
0.7033 Intermediate Similarity NPD5369 Approved
0.703 Intermediate Similarity NPD6404 Discontinued
0.7027 Intermediate Similarity NPD7100 Approved
0.7027 Intermediate Similarity NPD7101 Approved
0.7019 Intermediate Similarity NPD6008 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data